DexCom (DXCM) stock had a bullish inflow of $3.54 million worth of trades on uptick and an outflow of $2.72 million in downticks on Thursday. The total uptick to downtick ratio stood at 1.3. The net money flow into the stock was $0.82 million. The money flow data, which is calculated as the dollar value of composite uptick minus the downtick trades indicated bullish. The block trades had a total money flow of $1.38 million. $1.38 million of block trade during Uptick was observed, which shows continued buying by the smart money on every weakness. However, DexCom (DXCM) stock traded down $0.58 , and reached $78.11, a drop of -0.74% over the previous day. On a weekly basis, the stock is -1.85%, over the previous weeks close.
DexCom (DXCM) has been rated by 13 research analysts. Fundamentally, the highest shorterm price forecast for the stock is expected to reach $112 and the lowest price target forecast is $57. The average forecast of all the analysts is $87.6 and the expected standard deviation is $13.21. The stock has recorded a 20-day Moving Average of 3.02% and the 50-Day Moving Average is 13.47%.
DexCom (NASDAQ:DXCM): The stock opened at $78.58 on Thursday but the bulls could not build on the opening and the stock topped out at $78.88 for the day. The stock traded down to $76.21 during the day, due to lack of any buying support eventually closed down at $78.21 with a loss of -0.61% for the day. The stock had closed at $78.69 on the previous day. The total traded volume was 824,023 shares.
Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers for the treatment of people with and without diabetes. Its products consist of DexCom G4, DexCom G4 PLATINUM and DexCom Share System. The DexCom G4 PLATINUM with Share uses a wireless connection between a patients receiver and an application on the patients iPhone to transmit glucose information to applications on the mobile devices of up to five designated recipients or followers, who can remotely monitor a patients glucose information and receive alert notifications anywhere they have an Internet connection. SweetSpots data transfer service is a Medical Device Data System (MDDS) and allows researchers to control the transfer of data from certain diabetes devices to research tools and databases according to their own research workflows.